Background: Thoracoscopic lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) is a well-established option for early stage NSCLC, but the evidences are limited for octogenarians. Objective: The objectives of this multi-institutional study were to evaluate the post-operative outcomes of VATS-L in octogenarians and to estimate the post-operative quality of life (QoL) using a validated questionnaire (EuroQoL5D). Methods: Data from patients underwent VATS-L between 2014 and 2019 were analysed and divided into two groups: Group A (younger patients) and Group B (octogenarians). To define predictors for complications, univariate and multivariable logistic regression analysis were performed. Results: 7023 patients underwent VATS-L and 329 (4....
Background: Surgical resection is the main treatment for early stage lung cancer; the benefits of su...
BACKGROUND: Due to an increased life expectancy in a healthy aging population and a progressive inc...
OBJECTIVES: Resection is the standard treatment for stage I non-small cell lung cancer (NSCLC) in op...
Background: Thoracoscopic lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) is a well-establ...
Background: Octogenarians are rarely referred for surgical treatment of lung cancer owing to the mor...
International audienceObjective: We investigated on the benefit/risk ratio of surgery in octogenaria...
ObjectiveProspective analyses of quality of life in elderly patients after lobectomy are limited, ye...
Objective: Quality of Life (QoL) is an important predictor of patient's recovery and survival in lun...
Background and objective Conventional radical surgeries for lung cancer incur a large amount of trau...
Study objectives: Quality of life (QOL) following video-assisted thoracic surgery (VATS) major lung ...
IntroductionWith the increasing life span in the Western world, the number of octogenarians with res...
Purpose: Non-small cell lung cancer is the most common malignancy of the elderly, with 5-year surviv...
Objective: To assess the long-term impact of standard lobectomy on respiratory function in octogenar...
Results: The in-hospital mortality was 2.7 % without difference between groups. Group B had a lower ...
Objectives: To assess whether quality of life (QoL) was associated with cardiopulmonary complication...
Background: Surgical resection is the main treatment for early stage lung cancer; the benefits of su...
BACKGROUND: Due to an increased life expectancy in a healthy aging population and a progressive inc...
OBJECTIVES: Resection is the standard treatment for stage I non-small cell lung cancer (NSCLC) in op...
Background: Thoracoscopic lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) is a well-establ...
Background: Octogenarians are rarely referred for surgical treatment of lung cancer owing to the mor...
International audienceObjective: We investigated on the benefit/risk ratio of surgery in octogenaria...
ObjectiveProspective analyses of quality of life in elderly patients after lobectomy are limited, ye...
Objective: Quality of Life (QoL) is an important predictor of patient's recovery and survival in lun...
Background and objective Conventional radical surgeries for lung cancer incur a large amount of trau...
Study objectives: Quality of life (QOL) following video-assisted thoracic surgery (VATS) major lung ...
IntroductionWith the increasing life span in the Western world, the number of octogenarians with res...
Purpose: Non-small cell lung cancer is the most common malignancy of the elderly, with 5-year surviv...
Objective: To assess the long-term impact of standard lobectomy on respiratory function in octogenar...
Results: The in-hospital mortality was 2.7 % without difference between groups. Group B had a lower ...
Objectives: To assess whether quality of life (QoL) was associated with cardiopulmonary complication...
Background: Surgical resection is the main treatment for early stage lung cancer; the benefits of su...
BACKGROUND: Due to an increased life expectancy in a healthy aging population and a progressive inc...
OBJECTIVES: Resection is the standard treatment for stage I non-small cell lung cancer (NSCLC) in op...